STINGENI, L.; RAVASIO, R.; PALLADINO, C.; DI FINO, S.; LEVI, A.; RONCI, G.; GISONDI, P. Cost per responder of upadacitinib 30 mg and dupilumab 300 mg in patients with moderate-to-severe atopic dermatitis in italy. Global and Regional Health Technology Assessment, [S. l.], v. 12, n. 1, p. 70–79, 2025. DOI: 10.33393/grhta.2025.3458. Disponível em: https://journals.aboutscience.eu/index.php/grhta/article/view/3458. Acesso em: 12 mar. 2025.